Copyright Reports & Markets. All rights reserved.

Global Factor VIII Deficiency Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Factor VIII Deficiency Treatment Market Overview

      • 1.1 Product Overview and Scope of Factor VIII Deficiency Treatment
      • 1.2 Factor VIII Deficiency Treatment Segment by Type
        • 1.2.1 Global Factor VIII Deficiency Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Prophylaxis
        • 1.2.3 On-demand
        • 1.2.4 Inhibitor
      • 1.3 Factor VIII Deficiency Treatment Segment by Application
        • 1.3.1 Factor VIII Deficiency Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hemophilia A drugs
        • 1.3.3 Hemophilia A inhibitors treatment
        • 1.3.4 Von Willebrand disease treatment
      • 1.3 Global Factor VIII Deficiency Treatment Market by Region
        • 1.3.1 Global Factor VIII Deficiency Treatment Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Factor VIII Deficiency Treatment Market Size
        • 1.4.1 Global Factor VIII Deficiency Treatment Revenue (2014-2025)
        • 1.4.2 Global Factor VIII Deficiency Treatment Production (2014-2025)

      2 Global Factor VIII Deficiency Treatment Market Competition by Manufacturers

      • 2.1 Global Factor VIII Deficiency Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Factor VIII Deficiency Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Factor VIII Deficiency Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Factor VIII Deficiency Treatment Production Sites, Area Served, Product Types
      • 2.5 Factor VIII Deficiency Treatment Market Competitive Situation and Trends
        • 2.5.1 Factor VIII Deficiency Treatment Market Concentration Rate
        • 2.5.2 Factor VIII Deficiency Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Factor VIII Deficiency Treatment Production Market Share by Regions

      • 3.1 Global Factor VIII Deficiency Treatment Production Market Share by Regions
      • 3.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Factor VIII Deficiency Treatment Production
        • 3.4.1 North America Factor VIII Deficiency Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Factor VIII Deficiency Treatment Production
        • 3.5.1 Europe Factor VIII Deficiency Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Factor VIII Deficiency Treatment Production (2014-2019)
        • 3.6.1 China Factor VIII Deficiency Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Factor VIII Deficiency Treatment Production (2014-2019)
        • 3.7.1 Japan Factor VIII Deficiency Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Factor VIII Deficiency Treatment Consumption by Regions

      • 4.1 Global Factor VIII Deficiency Treatment Consumption by Regions
      • 4.2 North America Factor VIII Deficiency Treatment Consumption (2014-2019)
      • 4.3 Europe Factor VIII Deficiency Treatment Consumption (2014-2019)
      • 4.4 China Factor VIII Deficiency Treatment Consumption (2014-2019)
      • 4.5 Japan Factor VIII Deficiency Treatment Consumption (2014-2019)

      5 Global Factor VIII Deficiency Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Factor VIII Deficiency Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Factor VIII Deficiency Treatment Price by Type (2014-2019)
      • 5.4 Global Factor VIII Deficiency Treatment Production Growth by Type (2014-2019)

      6 Global Factor VIII Deficiency Treatment Market Analysis by Applications

      • 6.1 Global Factor VIII Deficiency Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Factor VIII Deficiency Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Factor VIII Deficiency Treatment Business

      • 7.1 Bayer HealthCare
        • 7.1.1 Bayer HealthCare Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.1.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.1.3 Bayer HealthCare Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 CSL
        • 7.2.1 CSL Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.2.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.2.3 CSL Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Grifols
        • 7.3.1 Grifols Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.3.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.3.3 Grifols Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Novo Nordisk
        • 7.4.1 Novo Nordisk Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.4.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.4.3 Novo Nordisk Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Pfizer
        • 7.5.1 Pfizer Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.5.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.5.3 Pfizer Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Shire
        • 7.6.1 Shire Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.6.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.6.3 Shire Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Alnylam Pharmaceuticals
        • 7.7.1 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.7.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.7.3 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Amarna Therapeutics
        • 7.8.1 Amarna Therapeutics Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.8.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.8.3 Amarna Therapeutics Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Biogen Idec
        • 7.9.1 Biogen Idec Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.9.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.9.3 Biogen Idec Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 BioMarin Pharmaceutical
        • 7.10.1 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Production Sites and Area Served
        • 7.10.2 Factor VIII Deficiency Treatment Product Introduction, Application and Specification
        • 7.10.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Catalyst Biosciences

      8 Factor VIII Deficiency Treatment Manufacturing Cost Analysis

      • 8.1 Factor VIII Deficiency Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Factor VIII Deficiency Treatment
      • 8.4 Factor VIII Deficiency Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Factor VIII Deficiency Treatment Distributors List
      • 9.3 Factor VIII Deficiency Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Factor VIII Deficiency Treatment Market Forecast

      • 11.1 Global Factor VIII Deficiency Treatment Production, Revenue Forecast
        • 11.1.1 Global Factor VIII Deficiency Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Factor VIII Deficiency Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Factor VIII Deficiency Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Factor VIII Deficiency Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Factor VIII Deficiency Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Factor VIII Deficiency Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Factor VIII Deficiency Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Factor VIII Deficiency Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Factor VIII Deficiency Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Factor VIII Deficiency Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Factor VIII Deficiency Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Factor VIII Deficiency Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Factor VIII Deficiency Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Factor VIII Deficiency Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Factor VIII Deficiency Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Factor VIII Deficiency Treatment market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Factor VIII Deficiency Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Factor VIII Deficiency Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Bayer HealthCare
        CSL
        Grifols
        Novo Nordisk
        Pfizer
        Shire
        Alnylam Pharmaceuticals
        Amarna Therapeutics
        Biogen Idec
        BioMarin Pharmaceutical
        Catalyst Biosciences

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Prophylaxis
        On-demand
        Inhibitor

        Segment by Application
        Hemophilia A drugs
        Hemophilia A inhibitors treatment
        Von Willebrand disease treatment

        Buy now